{"nct_id":"NCT05843643","title":"Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-07-19","start_date_type":"ACTUAL","primary_completion_date":"2026-12","primary_completion_date_type":"ESTIMATED","completion_date":"2027-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}